Introduction
The pivotal role that amyloid-b peptides (Abs) play on Alzheimers disease (AD) is universally accepted.
[1] However, controversy still exists on whether the amyloid deposits or the oligomeric Ab species are the primary cause of AD. [2] The steady-state level of Ab in the brain represents a balance between its biosynthesis, from the processing of amyloid-precursor-protein (APP) by a-and b-secretases, and its catabolism, including proteolytic degradation, cell-mediated clearance, and active and passive transport out of the brain. In this respect, many proteases regulate cerebral Ab level and, therefore, they represent a new interesting target in AD treatment. [3] Alteration of metal homeostasis (metallostasis) has also been advocated as a key feature in the development and progression of AD, even though a detailed understanding of the molecular mechanisms associating metal alteration and neurodegeneration is still far from being understood. [4] This is due not only to the experimental difficulties to obtain unambiguous analytical data on AD brain that allow the assessment of metallostasis alteration but also to the complex Abstract: Accumulation of neurotoxic amyloid-b peptide (Ab) and alteration of metal homeostasis (metallostasis) in the brain are two main factors that have been very often associated with neurodegenerative diseases, such as Alzheimers disease (AD). Ab is constantly produced from the amyloid-A C H T U N G T R E N N U N G precursor-protein APP precursor and immediately catabolized under normal conditions, whereas dysmetabolism of Ab and/or metal ions seems to lead to a pathological deposition. Although insulin-degrading enzyme (IDE) is the main metalloprotease involved in Ab degradation in the brain being up-regulated in some areas of AD brains, the role of IDE for the onset and development of AD is far from being understood. Moreover, the biomolecular mechanisms involved in the recognition and interaction between IDE and its substrates are still obscure. In spite of the important role of metals (such as copper, aluminum, and zinc), which has brought us to propose a "metal hypothesis of AD", a targeted study of the effect of metallostasis on IDE activity has never been carried out. In this work, we have investigated the role that various metal ions (i.e., Cu 2 + , Cu + , Zn 2 + , Ag + , and Al 3 + ) play in modulating the interaction between IDE and two Ab peptide fragments, namely Ab 1- 16 and Ab [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] . It was therefore possible to identify the direct effect that such metal ions have on IDE structure and enzymatic activity without interferences caused by metalinduced substrate modifications. Mass spectrometry and kinetic studies revealed that, among all the metal ions tested, only Cu 2 + , Cu + , and Ag + have an inhibitory effect on IDE activity. Moreover, the inhibition of copper(II) is reversed by adding zinc(II), whereas the monovalent cations affect the enzyme activity irreversibly. The molecular basis of their action on the enzyme is also discussed on the basis of computational investigations. Keywords: copper · IDE · metalloenzymes · metals · zinc
and not yet fully understood role of different metal ions in the brain. [5] [6] [7] [8] In particular, copper has been implicated in Ab aggregation and neurotoxicity and it is generally accepted that in AD brains there is an excess of Cu in the extracellular space and in amyloid plaques. [9, 10] On the other hand, a decrease of the intracellular copper in AD relative to a healthy control brain is also reported. [9] Since intracellular copper is likely to be involved in the control of the Ab secretion pathway, the restoration of a normal intracellular copper level should result in the reduction of secreted Ab. [11] This seems to be supported by a decrease of Ab secretion in transgenic APP23 mice brain receiving an oral treatment of Cu-supplemented water [12] and in toxic-milk mice with a mutant ATPase7b transporter that favors elevated intracellular Cu levels. [13] Additionally, although the mechanism through which the metal chelating agent clioquinol (CQ) may reduce AD progression has not been fully elucidated, it has been reported that CQ increases the intracellular level of Cu, promoting Ab degradation mediated by metalloproteases. [14] Altogether, these findings suggest that amelioration of AD pathology may be achieved through modulation of copper homeostasis and the recovery of the physiological copper distribution in the brain. [10] However, despite the hypothesis of a physiological relevance of metal ions in AD pathogenesis and the experimental evidence of a pivotal role of proteolytic enzymes in Ab accumulation in the brain, [15À17] only very few studies have been dedicated to the investigation of the metal effect on the regulation of proteolytic enzymes involved in Ab degradation. [18, 19] In this framework, it must be outlined that insulin-degrading enzyme (IDE), a zinc-protease involved in the degradation of a wide range of short polypeptides that vary considerably in sequence, such as insulin, amylin, and b-amyloid, [15, 20] is considered one of the main proteases involved in Ab degradation. [20] [21] [22] [23] It has been shown that IDE level and activity decrease during age, this being especially true in the cortex and hippocampus of AD brain. Although IDEs role in AD pathogenesis is still unclear, several genetic studies indicate that the IDE region on chromosome 10q is associated to AD late-onset and underline a link between IDE haplotypes and AD. Furthermore, since hyperinsulinaemia is associated with a high risk of AD, [24] it has been proposed that IDE could play a critical role in the mechanism associating hyperinsulinaemia and type 2 diabetes with AD. [25] Similar to other M16 family proteases, IDE shows a zincbinding motif, 108 
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112 H, that is inverted relative to the canonical metalloprotease motif, HEXXH. [26, 27] IDE is a homodimer, consisting of two 110 kDa subunits, each displaying two bowl-shaped halves connected by a flexible linker; its N-terminal and C-terminal domains form a chamber that is large enough to encapsulate different substrates. [28] This structure enables the metalloprotease to switch between two distinct conformations: an open state, which allows a way in for substrates and way out for products, and a closed' state, which allows substrate entrapment within the chamber. Inside the catalytic chamber, IDE features an exosite that is used to anchor the N-terminal end of IDE substrates. Interestingly, human IDE contains 13 cysteines that are not directly involved in the catalytic processes, as shown by the production of fully active forms of IDE containing all mutated 13 cysteines. [29, 30] However, it must be pointed out that sulfhydryl-directed reactions, such as alkylation (with N-ethylmaleimide), oxidative inactivation (with H 2 O 2 ), [31] and nitrosylation [32] inhibit IDE activity. Since IDE is considered a pharmacological target for AD and many studies focus on the investigation of the interaction between IDE and some of its possible modulators, [33, 34] in this work we have analyzed the effect of some metals on IDE enzymatic activity. The latter investigation is hindered by the fact that metal ions not only have an effect directly on IDE, [35] but they can also interact with b-amyloid, changing the Ab species in solution and promoting its aggregation. [17, 36] As IDE is able to degrade only monomeric Ab species, [37] the Ab peptides propensity to form oligomeric and/or aggregated species when bound to metal ions represents a serious problem if the effect of metal ions on IDE activity has to be studied. For this purpose, it is important to assess the metal coordination properties of IDE substrates and to distinguish the effect on substrate from the effect on IDE activity and conformation. Here, the effects of various metal ions on IDE activity was studied by using two Ab peptide fragments that show distinct characteristics: Ab 1-16 that encompasses the amino acid residues involved in the coordination to d-block metal ions [38] and Ab [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] that was chosen not only because it does not contain metal ion binding sites, but also because it has been reported that the preferred initial cleavages of Ab 1-40 occur at residues 18-21. [39] The knowledge of the metal complex species existing at different peptide/metal concentrations and their affinity constants [40, 41] allowed us to discriminate between the changes on the enzyme proteolytic activity due to the interactions of various metal ions (Cu 2 + , Cu + , Ag + , Al 3 + , Zn 2 + ) directly with IDE from those due to the alterations of the substrate features induced by the investigated metal ions.
Copper was identified as the only metal ion, among those scrutinized, that is able to strongly inhibit IDE proteolytic activity. Moreover, it is known that the oxidation state of some metals (i.e. copper) may be different in relation to cellular compartments. Although there is a lack of a definitive study that clearly establishes within which cellular compartment insulin and Ab peptide hydrolysis occurs, [20] it is known that IDE is mainly located intracellularly in the cytosol, peroxisomes, endosomes, and mithocondria, in which copper is mainly present as Cu + . In addition, a small portion of IDE is found extracellularly and on the plasma membrane, [42] in which copper is mainly present as Cu 2 + . For these reasons, an investigation has been carried out also for the effect on IDE activity by Cu + and Ag + , which exhibits similar coordination features to Cu + and sometimes is used as a model (avoiding the instability of Cu + in water in the absence of reducing agents). [43] Experimental Section Materials and methods: IDE, His-Tag, rat, recombinant, from Spodoptera frugiperda was purchased from Calbiochem (lot: D00040860) and its activity was verified by carrying out enzymatic digestion of insulin solutions according to the experimental procedure previously reported. [44] Phosphate buffer solution (PBS), a-cyano-4-hydroxycinnamic acid (CHCA), trifluoroacetic acid (TFA), acetonitrile, Ac 2 Cu, KAlA C H T U N G T R E N N U N G (SO 4 ) 2 , AgNO 3 , and Ac 2 Zn were all purchased from Sigma-Aldrich, whereas ZipTip C18 pipette tips were from Millipore. High-purity water (Milli-Q Element Ultrapure Water) was used for preparation of all the solutions. All N-fluorenylmethoxycarbonyl (Fmoc)-protected amino acids, 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium tatrafluoroborate (TBTU), and NovaSyn TGR resin were obtained from Novabiochem (Switzerland); Fmoc PAL-PEG resin, N,N-diisopropylethylamine (DIEA), and
were obtained from Applied Biosystems. N-hydroxybenzotriazole (HOBt), triisopropylsilane (TIS), and piperidine (Biotech grade) were purchased from Sigma-Aldrich. DMF (peptide synthesis grade) was obtained from Labscan Analytical Sciences. All the chemicals were of the highest available grade and were used without further purification.
Preparative reversed-phase HPLC (RP-HPLC) was carried out by using a Varian PrepStar 200 model SD-1 chromatography system equipped with a Prostar photodiode array detector with detection at 222 nm. Purification was carried out by eluting with solvents A (0.1 % TFA in water) and B (0.1 % TFA in acetonitrile) on a Varian Microsorb 300 C18 250 41.4 mm (300 pore size, 10 mm particle size) column, at flow rate of 30 mL min À1 . Analytical RP-HPLC analyses were performed by using a Waters 1525 instrument equipped with Waters 2996 photodiode array detector with detection at 222 nm. The peptide samples were analyzed by using gradient elution with solvents A and B on a Vydac C 18 250 4.6 mm (300 pore size, 5 mm particle size) run at a flow rate of 1 mL min À1 .
Peptides synthesis and purification: The Ab 1-16 and Ab [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] peptides were synthesized by standard solid-phase peptide synthesis on a Pioneer Peptide Synthesizer. All the amino acid residues were introduced according to the HATU/DIEA activation method for the Fmoc chemistry on Fmoc PAL-PEG resin (substitution 0.18 mmol g
À1
). All the coupling reactions were carried out under a four-fold excess of amino acid at every cycle. Fmoc deprotection was achieved at every cycle with 20 % piperidine solution in DMF.
The peptides were cleaved from their respective resins and simultaneously deprotected by treatment with a mixture of TFA/TIS/H 2 O (95/2.5/2.5 v/v) for 2 h at room temperature. Each solution containing the free peptide was separated from the resin by filtration and concentrated in vacuo at 30 8C. All peptides were precipitated with cold freshly distilled diethyl ether. The precipitate was then filtered, dried under vacuum, redissolved in water, and lyophilized. The crude peptides were purified by preparative RP-HPLC, as described below. Mass spectrometric measurements: Electrospray ionization ESI-MS measurements were carried out by using a Finnigan LCQ DECA XP PLUS ion trap spectrometer operating in the positive ion mode and equipped with an orthogonal ESI source (Thermo Electron Corporation, USA). Sample solutions were injected into the ion source at a flow rate of 5 ml min À1 , by using nitrogen as a drying gas. The mass spectrometer operated with a capillary voltage of 46 V and capillary temperature of 210 8C, whereas the spray voltage was set at 4.3 kV.
Atmospheric pressure MALDI (AP-MALDI)/MS measurements were carried out on the same spectrometer, which was fitted with a MassTech (USA) AP-MALDI source. The latter consists of a flange containing a computer-controlled X-Y positioning stage and a digital camera, and is powered by a control unit that includes a pulsed nitrogen laser (wavelength 337 nm, pulse width 4 ns, pulse energy 300 mJ, repetition rate up to 10 Hz) and a pulsed dynamic focusing (PDF) module that imposes a delay of 25 ms between the laser pulse and the application of the high voltage to the AP-MALDI target plate. Laser power was attenuated to about 65 %. The target plate voltage was 1.8 kV. The ion trap inlet capillary temperature was 210 8C. Capillary and tube lens offset voltages of 30 and 15 V, respectively, were applied. Other mass spectrometer parameters were as follows: multipole 1 offset at À3.75 V, multipole 2 offset at À9.50 V, multipole RF amplitude 400 V, lens at À24.0 V, and entrance lens at À88.0 V. Xcalibur software was used for the elaboration of mass spectra.
Enzymatic assays were carried out by preparing Ab 1-16 and Ab [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] solutions in PBS buffer (150 mm) at various peptide/enzyme concentration ratios. All solutions, after a specific period of incubation at 37 8C, were desalted and concentrated by using ZipTips C18 . One drop of the purified solution was spotted on the target plate and, when dried, covered by a drop of matrix solution (CHCA = 5 mm) in 30 % of TFA (0.1 %) and 70 % of CH 3 CN.
For the experiments with metal ions, aqueous solutions of Ac 2 Cu, KAl-A C H T U N G T R E N N U N G (SO 4 ) 2 , AgNO 3 , or Ac 2 Zn were added to the aliquots of peptide solutions to obtain the desired concentration of metal. To study the effect of copper(I) on IDE enzymatic activity, an excess of ascorbic acid (Sigma) was added to an oxygen-free reaction solution with [Cu
. [45] The latter was synthesized as follows: CH 3 CN (50 mL) in an Erlenmeyer flask (100 mL) was added to Cu
). An excess of powdered metallic copper (1.9 g) was then added and the reaction mixture stirred for 4 h at room temperature. The solution was then filtered by using a medium porosity frit, and the filtrate concentrated by vacuum tõ 20 mL. Diethyl ether (~25 mL) was added slowly to the filtrate and the solution cooled overnight to yield white needle crystals of [Cu 4 ) that was used as the source of copper(I) ion in the enzymatic assay. Because of the isotopic composition, molecular species are detected in the mass spectra as clusters of peaks; to simplify their assignments, the reported calculated values refer to monoisotopic m/z. HPLC analysis of Ab 1-16 and Ab [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] hydrolysis by IDE: Ab 1-16 and Ab 1-28 peptides were incubated at 37 8C for 6 h with 10 nm IDE in 0.5 mm phosphate buffer, pH 7.3, in the presence or the absence of Cu I (100 mm), Cu II (100 mm), Ag I (100 mm), or Zn 2 + (100 mm); when metals are present, before addition of the substrate, they are previously incubated with IDE at 37 8C for 15 min, a time sufficient for the complete effect of the metal, since longer incubation times did not affect the enzymatic kinetics. Ab 1-40 (previously dissolved in 100 % DMSO) was incubated at 37 8C for 5 h with 10 nm IDE in phosphate buffer. Aliquots were taken at different time intervals (i.e., 0 h, 30 min, 1 h, 2 h, 3 h, 5 h) and the reactions were stopped by addition of EDTA (0.5 mm). Samples were applied to a C18 reverse-phase HPLC column (Surveyor, Thermo Finnigan) and eluted at a flow rate of 1 mL min À1 by using a linear gradient: 95 % eluent A (H 2 O + 0.1 % TFA) and 5 % eluent B (CH 3 CN + 0.1 % TFA), with absorbance monitored at 220 and 214 nm.
Data were analyzed by the double reciprocal plot of velocity versus substrate concentration according to Equation (1):
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in which E 0 is the total enzyme concentration, v is the observed velocity (expressed as M s À1 ), K m is the Michaelis-Menten equilibrium constant (roughly corresponding to the substrate dissociation equilibrium constant), k cat is the velocity (expressed as s À1 ) of the rate-limiting step, and
[S] is the substrate concentration.
If a metal binds only the enzyme, its modulatory effect on IDE activity shows the features of a noncompetitive regulation and it may be described by Scheme 1. This last parameter refers to the alteration on K M when the substrate is bound to the enzyme and/or the alteration on K m when the metal is bound to the free enzyme, respectively (see Scheme 1).
A value of a < 1 indicates that the metal and the substrate increase their reciprocal affinity, displaying a positive interaction, whereas a > 1 indicates that the metal and the substrate decrease their reciprocal affinity, displaying a negative interaction, with a = 1 indicating a nonreciprocal interaction.
As from Scheme 1, the two elements of Equation (1) can be analyzed separately [see Eqs: (2a) and (2b)]:
in which obs K m and obs k cat are the observed Michaelis-Menten equilibrium constant and the rate-limiting step velocity, respectively, at a given metal concentration, K m and k cat are the same parameters in the absence of the metal, K M and a have the same meaning described for Scheme 1. It must be pointed out that while the parameter a is clearly dependent on the different substrate, the parameter K M is not, being associated to the dissociation equilibrium constant of that metal (either Cu 2 + or Cu + or else Ag + ) of the free enzyme.
In the case of metal binding to both enzyme and the substrate the regulatory effect of the metal on IDE activity may be described by Scheme 2, in which all parameters have the same meaning as in Scheme 1.
Molecular dynamics: Molecular dynamics (MD) simulations were performed by starting from the X ray structure of Free-IDE (pdb code 2JG4). [46] The engineered mutation of phenylalanine 831 was replaced with the tyrosine in order to have the active protein. A selected portion of the protein containing the binding site (residues 100-122, 172-195, and 811-855) was solvated in a cubic box containing 3272 water molecules and two chlorum atoms were added to ensure charge neutrality. Zinc coordination site (Zn, His108, His112, Glu189, and Glu111) was kept fixed considering electrostatics and Lennard-Jones parameters according to Hoops et al. [47] In addition, cysteines 812 and 819 of the same domain were coordinated to Cu + ion (IDE-Cu + ) and then solvated with the free-IDE system. Two MD simulations of free-IDE and IDE-Cu + were run, by using the NAMD code, [48] with the amber99SB force field and TIP3P model for water. [49] Cu + -sulfur potential [50] was used to treat the binding of Cu + to cysteines 812 and 819. To assess the trustworthiness of the Cu + -sulfur potential in combination with Amber99SB force field, an additional control simulation was carried out on the structure of ATX1, the yeast Cu I metallochaperone. [51] These sets of parameters are fully suitable with the Amber99SB force field, as shown from the values of Cu-S coordination distance and the S-Cu-S angle, both of them fluctuating around their equilibrium values 2.14 AE 0.06 and 171.1 AE 0. Both free-IDE and IDE-Cu + systems were equilibrated by using a Langevin dynamics and the standard barostat implemented in NAMD for 5 ns, with subsequent 125 ns in the NpT ensemble, applying periodic boundary conditions. The Particle Mesh Ewald method was used for treating long-range electrostatic interactions. [52] Root-mean-square deviations from the selected X-ray structure are reported in Figures 2S and 3S of the Supporting Information for the two dynamics. Table 1 for the assignment and Scheme 3a for cleavage sites). Although under these experimental conditions it is not possible to quantitatively evaluate the activity of IDE (because of the differences in the ionization process for the different peptide fragments and the need of internal standards [53] ), it is evident from the relative peak intensities of the detected peaks that Cu + and Cu 2 + are strong inhibitors; Zn 2 + seems to be a slight activator of the IDE proteolytic action, whereas Al 3 + does not seem to have any effect on Scheme 1. Regulatory effect of the metal on IDE activity in the case of metal binding to the enzyme only. K M is the dissociation equilibrium constant of the metal (which can be either Cu 2 + , Cu + or Ag + ) to the free enzyme and a is the interaction factor. See text for discussion. Scheme 2. Regulatory effect of the metal on IDE activity in the case of metal binding to both enzyme and substrate. Scheme 3. Amino acid sequence of the two synthesized peptides Ab 1-16 (a) and Ab [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] (b) tested for IDE activity assays. Big arrows indicate specific IDE cleavage sites, whereas the small ones are indicative of other nonspecific cleavages that are less favorable and mainly occur at a very long incubation time (! 24 h), possibly due to peptide autolysis. the enzyme proteolytic activity (the spectrum recorded with the addition of KAlA C H T U N G T R E N N U N G (SO 4 ) 2 is similar to that obtained without any metal ion, see Figure 1b) . Indeed, the mass spectrum detected in the presence of Cu + or Cu 2 + (Figure 1c ) is approximately identical to the one detected in the absence of the enzyme (Figure 1a) . On the contrary, the peaks attributed to the intact Ab 1-16 peptide decrease when Zn 2 + is present in the digestion solution (Figure 1d ), being substituted with the peptide fragments generated by IDE proteolytic action. However, it is important to highlight that in the case of Zn 2 + , the observed activation effect was not equally recorded for all the enzyme lots purchased, as no effect on IDE proteolytic action was detected for some of them. In particular, we noticed that the activation effect was inversely correlated with the overall proteolytic activity of the examined lot, measured by standard insulin activity assays (data not shown). Since IDE is a Zn metalloprotease, it is very likely that the low activity of some enzyme lots might be related to the presence of some enzyme molecules that are missing the catalytic Zn 2 + ion. Adding Zn 2 + to the solution possibly restores the catalytic Zn 2 + ion increasing the overall enzyme activity. On the contrary, the strong copper(II) inhibitor effect was recorded for all the enzyme lots tested and did not depend on the overall enzyme activity. Moreover, the same results were found even at different peptide/metal ratios (solutions containing [Ab 1-16 ] = 40 mm and [Ac 2 Cu] = 5 mm, 100 mm, or 3.5 mm produced the same spectrum reported in Figure 1c) . From the different species distributions obtained for the three different peptide/metal concentration ratios investigated (see Figure 4S of the Supporting Information), [40, 41] it is possible to see that the enzyme inhibition must be carried out by different species in the three cases. Indeed, whereas in the case of [Ab 1-16 ] = 40 mm and [Ac 2 Cu] = 100 mm or 3.5 mm, both free and hydrolytic copper species are abundant in solution, when [Ab 1-16 ] = 40 mm and [Ac 2 Cu] = 5 mm, all the copper(II) in solution is bound to the substrate. Therefore, since in all three cases the same total inhibitory effect is observed, both free copper(II) and copper(II)/Ab 1-16 complex must be able to strongly inhibit IDE activity. It turns out that it is very difficult to interpret the effect of metal ions on IDE activity when we employ substrates that are able to bind metal ions; thus, the presence of different percentages of distinct species at various metal/ peptide ratios, as well as the conformational metal-induced changes on substrates, can mask the effect of free metal ions on the enzyme conformation and activity capabilities. Therefore, to cast light on the role of different metal ions on IDE, it is necessary to carry out the activity measurements also 
Results and Discussion

A C H T U N G T R E N N U N G (MeCN) 4 ]A C H T U N G T R E N N U N G (ClO
H T U N G T R E N N U N G (MÀLys)ÀH 2 O + 2 NaÀH)]
+ . The latter two species are due to a small contamination carried over from the peptide synthesis that does not affect the analysis. Peaks marked with * are Ab fragments generated by the action of IDE and their assignment is reported in Table 1 . See text for discussion. Table 1 . Assignment for the peptide fragments detected in Figure 1 due to the cleavage of the peptide Ab 1-16 by the action of IDE (see Figure 2 for the cleavage sites). Fragment 1-15 is also detected in Figure 1a as an impurity carried over from the peptide synthesis but it does not affect the enzymatic assay (after enzymatic digestion peak at m/z: 1512.0 assigned to the fragment 4-15 is detected because of the 1-15 impurity). Calculated peaks refer to monoisotopic protonated species. Dimeric Ab 1-16 is also detected at m/z: 3958.6 and it is possible to see that IDE is able to degrade also such species producing some of the fragments reported (see m/z > 2000). Note that all dimeric species are detected as sodiated peaks. The assignment of the latter could not be verified by MS/ MS experiments due to the low signal/noise ratio and it is only tentative. In Figure 2 the spectra obtained by AP/MALDI MS for the digestion of Ab [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] by IDE in the presence and absence of different metal ions are reported (see Table 2 for the assignment and Scheme 3b for cleavage sites). As in the case of Ab 1-16 , both Cu 2 + and Cu + are strong inhibitors of IDE activity, whereas aluminum does not have any effect on the IDE degradative action. The same result as for Ab 1-16 was obtained for Ab [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] 
Kinetic studies of IDE proteolytic activity versus Ab peptides
Effect of divalent cations on IDE processing of fragments Ab 1-16 and Ab [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] : To further assess how the different metal ions above mentioned are able to affect IDE enzymatic activity, steady-state kinetics of IDE on Ab 1-40 and on its fragments Ab 1-16 and Ab [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] were performed (Figure 3) . Data have been analyzed according to Equation (1) (see Materials and Methods in the Experimental Section) and catalytic parameters are reported in Table 3 . The catalytic parameters for Ab 1-40 are in accordance with values already reported in the literature for this IDE substrate. [54] From Figure 3 it is evident that IDE has a slightly higher enzymatic activity toward the complete Ab 1-40 peptide with respect to its shorter peptide fragments, which can be attributed to an increased substrate affinity for Ab 1-40 (corresponding to a . Peptide concentration was 40 mm, IDE was 1.8 nm, whereas the metal concentration if added was 100 mm. The same results were obtained in triplicate and the reaction time was 1 h. Ab fragments generated by the action of IDE and their assignment verified by MS/MS experiments are reported in Table 2 . Table 2 . Assignment for the peptide fragments detected in Figure 2 due to the cleavage of the peptide Ab [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] by the action of IDE (see Figure 2 for the cleavage sites). Calculated peaks refer to monoisotopic protonated species. Table 3 .
lower value of K m , see Table 3 ). This slightly higher affinity is probably due to the fact that the whole peptide sequence is involved in the interaction with IDE and also the 29-40 portion of Ab 1-40 contributes to the substrate binding free energy to IDE. On the other hand, it also turns out that the rate constant for the substrate cleavage rate-limiting step (corresponding to k cat , see Table 3 ) is lower for the Ab 1-40 peptide, whereas the fastest rate is observed for the Ab [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] peptide, which contains only three bonds suited for IDE cleavage [29] (see Scheme 3b). In view of these small differences between Ab 1-40 and the peptide models, Ab [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] and Ab 1-16 were used to study how the kinetics parameters of the IDEAb interaction are affected by metal ions. In Figure 4 the Lineweaver-Burk plots of the enzymatic processing by IDE of Ab 1-16 and Ab [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] peptides in the presence of Cu 2 + and after the subsequent addition of Zn 2 + are reported. In the case of the enzymatic processing of the Ab 16-28 peptide, we have observed a moderate inhibition by Cu 2 + (Figure 4a ), whereas for the Ab 1-16 peptide the addition of Cu 2 + essentially abolishes any enzymatic activity, such that after 5 h less than 5 % of the substrate has been processed by IDE (data not shown). Since the Ab 16-28 peptide does not bind Cu 2 + , the inhibitory effect of Cu 2 + on IDE activity toward this peptide is due only to the interaction of the ion with IDE (see Figure 4a ) and it has been analyzed according to Scheme 1 (see Materials and Methods in the Experimental Section), showing the features of a noncompetitive inhibition. Therefore, in the processing of the Ab [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] peptide, the role of Cu 2 + is to modulate the equilibrium toward the form E M S (see Scheme 1), which is postulated to be devoid of enzymatic activity. Figure 4 and [55] Therefore, while further research is required to account for all differences in K d determinations in various laboratories, in the case of the Ab 1-16 peptide used here, a detailed study of the metal-Ab 1-16 complexes speciation has been already reported by our group. [40] It was found that the affinity of Cu 2 + for this peptide is very high (K d < 1 nm), such that, at this metal/peptide ratio (see Figure 4S in the Supporting Information), we can consider the Ab 1-16 peptide always fully Cu 2 + -bound and Scheme 2 must be considered (see Materials and Methods in the Experimental Section). 
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Under these conditions, the addition of a 100 mm Cu 2 + brings about an almost complete inhibition of the IDE activity (see above), and this much larger inhibitory effect of Cu 2 + on the enzymatic processing of the Ab 1-16 peptide with respect to the Ab 16-28 peptide should be accounted for by a much smaller value of a (! 0.01) in Scheme 2 and Equation (2b) (since K Cu is the same, as previously determined for the Ab 16-28 peptide, see above). In other words, the simultaneous presence of bound Cu 2 + on the enzyme and on the substrate (occurring only for the Ab 1-16 peptide) has a synergistic effect on the equilibria reported in Schemes 1 and 2, driving much more the equilibrium toward the inactive form E Cu S Cu (corresponding to E M S M , see Scheme 2) with respect to E Cu S (corresponding to E M S, see Scheme 1). In any case, the effect of Cu 2 + should be related to a conformational change of the Ab 1-16 peptide, which greatly affects its binding properties to IDE.
Although it has been widely reported that the binding sites of Cu II and Zn II to Ab peptides do, at least partially, overlap, [56] in terms of the K d , Cu 2 + binding to Ab 1-16 [40] is several order of magnitudes stronger than Zn 2 + binding. [41] For this reason, as is reported in Figure 5S (Figure 4) . The latter results show that the strong inhibitor effect of Cu 2 + on the enzyme can be easily reversed by the addition of Zn 2 + and this effect can be observed for both substrates (data not shown).
It is very important to underline that copper is markedly enriched in amyloid deposit where it coordinates Ab. As a matter of fact, copper concentration in the AD brain (= 390 mm) is several-fold higher than in normal brain (= 70 mm). [6] This concentration difference encompasses the value of Cu II binding to IDE (i.e., K Cu = 210 mm, see above), which clearly indicates that in normal brain IDE is essentially Cu II -free whereas in AD brain most of Cu II could be bound to IDE, affecting its enzymatic activity; therefore, the Cu II affinity values reported might have some pathophysiological significance, underlying a possible metal effect also under in vivo conditions. Effect of monovalent cation on IDE processing of fragments Ab 1-16 and Ab [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] : The effect of Cu + or Ag + on the enzymatic activity of IDE is drastically different (see Figure 4b ) from that observed for Cu 2 + (see Figure 4a ). On the other hand, the effect of Cu + and Ag + on the IDE activity are similar; therefore, the effect of Ag + has been more extensively investigated, because it is easier to be handled (Cu the inhibition response in IDE is substrate dependent and modified IDE retains substrate specificity. In the case in which the Ab 1-16 peptide cysteines are likely not to play a major role, a different mechanism should come into play. Thus, since Cu 2 + shows a higher affinity than Zn 2 + for the imidazole nitrogen atoms of peptide ligands forming the macrochelate rings, [40, 41] it is plausible to foresee that the added Cu 2 + substitutes Zn 2 + in the catalytic site, leading to an inhibition of the enzyme activity of IDE due to the different coordination requirements of the two metal ions.
The inhibitory effect of Cu 2 + and Ag + (or Cu + ) on IDE activity reinforces the involvement of abnormal copper homeostasis for Ab deposition in AD brain. Pathological increase of metal concentration could thus lead not only to the enhanced amyloid deposition but also to an increased concentration of soluble Ab, bringing about a vicious cycle that may markedly contribute to amyloid plaques formation.
Copper(I) binding to IDE affects local dynamics: It has been shown that IDE is inhibited irreversibly by oxidation, nitrosylation, and alkylation, that covalently modify cysteine residues. [31, 32] In particular, the two cysteines Cys812 and Cys819 have been identified as the main residues directly involved in these inhibitor effects, whereas Cys 110 is oriented in the opposite direction with respect to the active site and is not critical for enzyme inhibition (see reference [29] and Figure 6S in the Supporting Information). Interestingly, Cys812 and Cys819 are the only cysteines that possess the stereochemical requirements for the linear coordination of copper(I). For these reasons, we aimed at investigating the effects of the binding of copper(I) on IDE structure when Cys812 and Cys819 directly coordinate the monovalent cation. Unbiased molecular dynamics (MD) simulations were carried out by blocking Cys 819 and Cys 812 with Cu + and comparing the domain features of altered IDE with those of the native form.
The binding site of IDE involves a network of hydrophobic interactions, which regulate the site shape. In particular, Phe 848, Leu 846, belonging to the b-sheet, and Ile 814 and Ile 815, which are part of the short a-helix of domain 4, stabilize the interface between the b-sheet and its facial short a-helix. Cys 812 and Cys 819, belonging to the facial a-helix are mobile and tend to assist the hydrophobic network.
When such two cysteines are blocked with Cu + (IDE-Cu + ), the hydrophobic core is destabilized, since the a-helix, to which both cysteines belong, is more rigid. Consequently to the closure of the binding site, the b-sheet portion tends to rearrange, forming a new network of hydrophobic interactions by approaching Val 194, which is close to the Zn 2 + coordination site. Figure 5 shows the above-described conformational transition, which leads IDE-Cu + to be inactive. This transition appears evident from the distributions reported in Figure 6 concerning the distance between the CH side chain of Val 194 and the CH 2 group of Phe 848 (Figure 6a) , which shows an average distance of 25 in the native protein versus 7 in the IDE-Cu + -locked isoform. Furthermore, Tyr 831, which is important in assisting the entrance of the IDE substrate, moves far away from the metal coordination site (by about 10 ), inhibiting the protein activity (Figure 6b ). Such a destabilization is also reinforced by the lowering of the number of hydrophobic contacts (Figure 6c) .
The active cavity is subtly regulated by a metal environment that is able to coordinate the two cysteines Cys812 and Cys819. Unbiased MD simulations predict that metal-blocking effects directly alter the cavity size by more than 15 per unit ( Figure 5 ), drawing new horizons to further explore. www.chemeurj.org Figure 6 . a) Val 194-Phe848 (CH-CH 2 ) distance distribution, which shows the shift towards a tight structure adopted by IDE-Cu + . b) Distance distribution involving zinc and Tyr 831, higher in IDE-Cu + than in Free-IDE, due to the destabilization of the hydrophobic core caused by the coordination of Cys 812 and Cys 819 with Cu + . c) Number of hydrophobic contact distribution in Free-IDE and IDE-Cu + . In the latter, hydrophobic contacts are decreased of 15 % (a = IDE, c = IDE-Cu + ).
